Co-delivery of Gefitinib and chloroquine by chitosan nanoparticles for overcoming the drug acquired resistance

BACKGROUND: Acquired drug resistance is becoming common during cancer chemotherapy and leads to treatment failure in clinic. To conquer acquired drug resistance, nanotechnology has been employed to deliver drug. In this paper, we prepared chitosan nanoparticles (CS NPs) capable of entrapping Gefitin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Liang, Yang, Guang, Shi, Yijie, Su, Chang, Chang, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579980/
https://www.ncbi.nlm.nih.gov/pubmed/26395758
http://dx.doi.org/10.1186/s12951-015-0121-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579980/
https://www.ncbi.nlm.nih.gov/pubmed/26395758
http://dx.doi.org/10.1186/s12951-015-0121-5

Ejemplares similares